Assessing the clinical utility of protein structural analysis in genomic variant classification: experiences from a diagnostic laboratory
Open Access
- 22 July 2022
- journal article
- research article
- Published by Springer Nature in Genome Medicine
- Vol. 14 (1) , 1-16
Abstract
Background: The widespread clinical application of genome-wide sequencing has resulted in many new diagnoses for rare genetic conditions, but testing regularly identifies variants of uncertain significance (VUS). The remarkable rise in the amount of genomic data has been paralleled by a rise in the number of protein structures that are now publicly available, which may have clinical utility for the interpretation of missense and in-frame insertions or deletions. Methods: Within a UK National Health Service genomic medicine diagnostic laboratory, we investigated the number of VUS over a 5-year period that were evaluated using protein structural analysis and how often this analysis aided variant classification. Results: We found 99 novel missense and in-frame variants across 67 genes that were initially classified as VUS by our diagnostic laboratory using standard variant classification guidelines and for which further analysis of protein structure was requested. Evidence from protein structural analysis was used in the re-assessment of 64 variants, of which 47 were subsequently reclassified as pathogenic or likely pathogenic and 17 remained as VUS. We identified several case studies where protein structural analysis aided variant interpretation by predicting disease mechanisms that were consistent with the observed phenotypes, including loss-of-function through thermodynamic destabilisation or disruption of ligand binding, and gain-of-function through de-repression or escape from proteasomal degradation. Conclusions: We have shown that using in silico protein structural analysis can aid classification of VUS and give insights into the mechanisms of pathogenicity. Based on our experience, we propose a generic evidence-based workflow for incorporating protein structural information into diagnostic practice to facilitate variant classification.Keywords
Funding Information
- Wellcome Trust (Transforming Genomic Medicine Initiative (TGMI), WT200990/A/16/Z)
This publication has 83 references indexed in Scilit:
- Kelch-like 3 and Cullin 3 regulate electrolyte homeostasis via ubiquitination and degradation of WNK4Proceedings of the National Academy of Sciences, 2013
- The CUL3–KLHL3 E3 ligase complex mutated in Gordon's hypertension syndrome interacts with and ubiquitylates WNK isoforms: disease-causing mutations in KLHL3 and WNK4 disrupt interactionBiochemical Journal, 2013
- Impaired KLHL3-Mediated Ubiquitination of WNK4 Causes Human HypertensionCell Reports, 2013
- Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalitiesNature, 2012
- Using SIFT and PolyPhen to Predict Loss-of-Function and Gain-of-Function MutationsGenetic Testing and Molecular Biomarkers, 2010
- Stability effects of mutations and protein evolvabilityCurrent Opinion in Structural Biology, 2009
- DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl ResourcesThe American Journal of Human Genetics, 2009
- Intrinsically Disordered Proteins in Human Diseases: Introducing the D2ConceptAnnual Review of Biophysics, 2008
- Molecular architecture of Gα o and the structural basis for RGS16-mediated deactivationProceedings of the National Academy of Sciences, 2008
- SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modelingElectrophoresis, 1997